Digital Health Sector Sees Accelerated M&A Activity
The digital health industry is experiencing a wave of mergers and acquisitions as companies compete to achieve scale and integrate AI. Large platforms are acquiring specialist startups to add capabilities ranging from patient engagement to clinical decision support. The trend is creating a "land grab" for differentiated, AI-powered health services.
- The market is seeing a significant uptick in deal volume, with 195 mergers and acquisitions occurring in 2025, a 61% increase from 2024. This trend is expected to accelerate in 2026 as unprofitable, sub-scale companies consolidate to survive. - Artificial intelligence is the primary catalyst for M&A activity, with AI-native companies in areas like revenue cycle management and clinical documentation commanding the highest valuation premiums. The global market for AI in healthcare is projected to grow from $19.3 billion in 2023 to $187.7 billion by 2030. - Recent transactions show a trend of category leaders acquiring competitors to gain market share and expand geographically. Examples from early 2026 include musculoskeletal provider Sword Health buying Kaia Health and mental health platform Spring Health acquiring Alma. - A notable trend is "tapestry weaving," where digital health startups acquire other startups to add new capabilities. In the first quarter of 2025, 67% of M&A deals involved a digital health startup as the acquirer, up from 53% in 2024. - Large pharmaceutical companies are actively acquiring digital health and biotech firms to bolster their pipelines. Eli Lilly recently entered a definitive agreement to acquire Orna Therapeutics for up to $2.4 billion to enhance its genetic medicine capabilities. Similarly, Sanofi completed its acquisition of Dynavax to augment its vaccine portfolio. - Hospital CIO fatigue with managing numerous single-purpose vendors is driving a push for platform acquisitions. Larger incumbent companies are buying smaller "point solutions" to create more comprehensive, bundled service offerings. - Private equity firms are also fueling consolidation through a "buy and build" strategy, aggressively merging mid-sized companies to create larger, healthcare-focused service providers, particularly those with over $10 million in EBITDA. - While M&A is the more common exit strategy, the IPO market for digital health began to show signs of life in 2025, which could provide an alternative path for mature companies in 2026.
